RT Book, Section A1 Cooney, Judith A1 Grant, Christoffer A2 Ebert, Michael H. A2 Leckman, James F. A2 Petrakis, Ismene L. SR Print(0) ID 1158265136 T1 Tobacco Use Disorder T2 Current Diagnosis & Treatment: Psychiatry, 3e YR 2019 FD 2019 PB McGraw-Hill Education PP New York, NY SN 9780071754422 LK accessmedicine.mhmedical.com/content.aspx?aid=1158265136 RD 2024/03/29 AB Cigarette smoking is the leading cause of mortality in the United States, accounting for nearly 445,000 deaths, or one in five deaths per year (Centers for Disease Control and Prevention [CDC], 2009). Tobacco use accounts for more deaths annually than alcohol and drug use, motor vehicle accidents, HIV, suicide and homicide combined (CDC, 2002). Smokers tend to die prematurely, losing an average of about 14 years of life (CDC, 2009). Beyond mortality, smoking is linked to a large range of chronic and severe medical disorders that negatively impact health and function, including heart disease, cancer, pulmonary disease, infertility, sexual dysfunction. Although U.S. smoking prevalence rates have dropped from 50% in 1964 to about 19% currently (CDC, 2012), this still poses a large health and economic burden to smokers and to our society. Smoking prevalence rates are negatively correlated with education and socioeconomic status. Furthermore, smoking prevalence rates in individuals with psychiatric and substance use disorders are more than two to three times greater than rates among the general public (Lasser et al, 2000). Smokers with mental illness are large consumers of cigarettes, accounting for about 44% of all cigarettes smoked (Lasser et al, 2000).